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Abstract 
Recent developments in CBT emphasize the promotion of psychological flexibility to improve 
daily functioning for people with a wide range of health conditions. In particular, one of these 
approaches, Acceptance and Commitment Therapy (ACT), has been studied for treatment of 
chronic pain. While trials have provided good support for treatment effectiveness through follow-
ups of as long as seven months, the longer term impact is not known. The present study of 108 
participants with chronic pain examined outcomes three years after treatment completion and 
included analyses of two key treatment processes, acceptance of pain and values-based action. 
Overall, results indicated significant improvements in emotional and physical functioning relative 
to the start of treatment, as well as good maintenance of treatment gains relative to an earlier 
follow-up assessment. Effect size statistics were generally medium or large. At the three year 
follow-up, 64.8% of patients had reliably improved in at least one key domain. Improvements in 
acceptance of pain and values-based action were associated with improvements in outcome 
measures.  A “treatment responder” analysis, using variables collected at pre-treatment and 
shorter term follow-up, failed to identify any salient predictors of response. This study adds to 
the growing literature supporting the effectiveness of ACT for chronic pain and yields evidence 
for both statistical and clinical significance of improvements over a three-year period. 
 
 
 
 
 
 
 
Keywords: Acceptance, Values, Chronic Pain, Contextual Cognitive-Behavioral Treatment; 
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Introduction 
Cognitive Behavioral Therapy (CBT) has a significant record of success in the treatment 
of chronic pain (e.g., Hoffman, Papas, Chatkoff, & Kerns, 2007; Morley, Eccleston, & Williams, 
1999).  Nevertheless there are calls to improve upon the current standard treatments, such as 
by focusing greater attention on therapeutic processes, by selecting processes and methods 
known to produce improvements, and by considering treatment integrity (Eccleston, Morley, & 
Williams, 2009).  There are approaches within CBT that are attempting to meet these 
challenges. Some of these are referred to as contextual forms of CBT and include Acceptance 
and Commitment Therapy (ACT; Hayes, Strosahl, & Wilson, 1999).         
Currently there are at least eleven trials that provide evidence for the efficacy or 
effectiveness of ACT for chronic pain (see Vowles & Thompson, 2011 for a review). The 
majority of these studies include follow-up assessment, the longest of which has been a seven 
month interval (Wicksell, Ahlqvist, Bring, Melin, & Olsson, 2008).  These follow-up assessments 
suggest good maintenance of treatment effects achieved in ACT. The longer term effects of 
treatment, however, are not yet known. This issue is of particular relevance in chronic pain, 
where pain intensity, as well as other symptoms, are likely to persist after treatment, and there 
is a need for consistent engagement in new patterns of behavior over the long term, patterns 
that may be in some ways unnatural given the persistence of pain. 
The purpose of the present study was to extend the results from previous studies of ACT 
for chronic pain by examining outcomes in a cohort of patients three years after treatment 
completion. Outcomes through a three-month follow-up for these patients were previously 
reported by Vowles & McCracken (2008). Three specific objectives were identified for the longer 
term outcome data presented here. The first was to perform a rigorous analysis of longer term 
treatment outcomes, including significance testing, calculation of treatment effect sizes, and 
analyses of reliable change on key measures of functioning (Jacobson, Roberts, Berns, & 
McGlinchey, 1999).  The second objective was to investigate how changes in treatment process 
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variables, in this case acceptance of pain and values-based action, related to changes in 
treatment outcomes through the three year follow-up. Finally, we sought to perform an analysis 
of three-year “treatment responders”. Specifically, pre-treatment and treatment response 
variables were examined to determine if they could reliably predict who had maintained 
treatment benefits at the three year follow-up. 
Method 
All patients who had completed treatment between January 2005 and August 2006 were 
contacted three years following the end of treatment and asked to complete a questionnaire 
pack assessing physical and psychosocial functioning in relation to pain. In order to maximize 
response rates, a £10.00 gift card was included with the original mailing, patients were 
contacted by telephone on the day the questionnaires were sent out, and a reminder telephone 
call and letter were sent two and four weeks, respectively, after initial invitation was sent out. 
The study was approved by the local ethics board. 
Participants 
In total, there were 171 individuals who had completed treatment during the selected 
study period. There was a small proportion of these who were not contactable, either because 
they were deceased (n = 3) or had moved house and no address was traceable through the 
National Health Service database or through the Post Office (n = 2). Of the remaining 166 
patients, 108 completed the questionnaires, yielding an overall response rate of 65.1% of 
patients who were contactable. 
The majority of individuals who provided three year follow-up data were female (62.0%), 
White European (96.3%), and married or co-habitating (72.8%; divorced: 13.2%; single: 10.4; 
widowed: 3.8%). Demographic and pain characteristics were collected at treatment onset. At 
this initial point of contact, participants were on average 47.1 years of age (SD = 10.7) and had 
13.2 years of formal education (SD = 2.8).  Most were unemployed (70.4%) and receiving some 
type of disability or wage replacement (72.0%). Median pain duration was 96 months (range: 13 
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to 360). The most frequently identified site of pain was low back (46.3%), followed by 
shoulder/arms (18.6%), full body (15.8%), legs/pelvic region (9.2%), neck (3.7%), mid-back 
(3.7%), and other (e.g., head, abdominal; 2.7%). Most patients also identified one or more 
additional pain sites (57.4%).  
Measures 
 The questionnaire set completed at the three year follow-up was essentially identical to 
the sets completed at treatment onset, conclusion, and three month follow-up. A brief 
background inventory asked patients to report on usual pain intensity over the past week using 
a 0 (none) to 10 (worst imaginable) numeric rating scale, work status, and the number of pain-
related medical appointments that had occurred in the preceding six months, including primary 
care, specialist, and emergency department visits. 
 Missing responses were rare and occurred for less than 5% of items across all 
assessment points. For completion of all measures through the three month follow-up, a 
research assistant was available to assist patients with questionnaires and ensure completed 
responses. Rates of missing responses were similar for the three year follow-up data in 
comparison to for data collected at other time periods. 
Chronic Pain Acceptance Questionnaire (CPAQ) 
 Acceptance of pain was assessed using the 20-item CPAQ (McCracken, Vowles, & 
Eccleston, 2004). A total score and two subscale scores can be calculated. The first subscale, 
Activity Engagement, assesses the degree to which effective functioning occurs in a way that is 
not markedly restricted by pain and the second, Pain Willingness, assesses the extent to which 
respondents are willing to have pain without engaging in attempts to control it. The total score 
was used within most analyses in the present study; scores range from 0-120. The total and 
subscale scores of the CPAQ have demonstrated psychometric properties and the factor 
structure has been supported via confirmatory factor analysis (McCracken et al., 2004; 
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Reneman, Kijkstra, Geertzen, & Kijkstra, 2010; Vowles, McCracken, McLeod, & Eccleston, 
2008; Wicksell, Olsson, & Melin, 2009).  
Chronic Pain Values Inventory (CPVI) 
 The ACT model places particular importance on values-based action as a focus of 
treatment. Values are directions or qualities of action in domains of functioning. They are 
personally important and, when values-based actions are engaged in, they bring meaning and 
vitality to daily functioning. The CPVI (McCracken & Yang, 2006) measures values in six 
domains, including family, intimate/close interpersonal relationships, friends, work, and growth 
or learning. The importance of values held in each domain and success in following them are 
assessed on 0 (not at all important/successful) to 5 (extremely important/successful) scales. 
Three scores can be calculated: average importance; average success; and average 
discrepancy between importance and success. To date, the values success score has been 
most widely used in research as a reflection of values-based action, and there is evidence that 
greater success scores are associated with better concurrent and future functioning (McCracken 
& Yang, 2006; McCracken & Vowles, 2008) and greater levels of improvement following 
treatment (Vowles & McCracken, 2008). Within the present study, we report on all three CPVI 
scores. 
British Columbia Major Depression Inventory (BCMDI) 
The BCMDI (Iverson & Remick, 2004) is a 20 item measure of depression modeled after 
the Diagnostic and Statistical Manual of Mental Disorders criteria for Major Depressive Disorder 
(4th ed.; American Psychiatric Association, 1994). The first 16 items assess symptom severity 
and each symptom present is rated on a zero (symptom is absent) to five (very severe 
symptom) scale. The final four items evaluate the impact of symptoms on areas of work/school, 
family, and social activities. The symptom score was used in the present study; scores range 
from 0-80. Good evidence of psychometric properties has been demonstrated, as has good 
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sensitivity and specificity for a diagnosis of Major Depressive Disorder (Iverson & Remick, 
2004). 
Pain Anxiety Symptoms Scale-20 (PASS) 
 The total score of the 20-item PASS (McCracken & Dhingra, 2002) was used as a 
measure of pain-related fear and avoidance. The PASS has demonstrated a stable factor 
structure and good psychometric properties (McCracken & Dhingra, 2002; Roelofs et al., 2004), 
as well as strong correlations with the original 40-item PASS (McCracken, Zayfert, & Gross, 
1992). Scores range from 0-100. 
Sickness Impact Profile (SIP) 
 The SIP (Bergner, Bobbitt, Carter, & Gilson, 1981) is a 136-item measure of the effects 
of health on daily functioning. The measure includes twelve subscales that are combined to 
form a total score and three composite scores: physical disability, psychosocial disability, and 
“other” disability; scores range from 0-1. The SIP has been widely used in health care settings 
(Battié & May, 2001). The present analyses used the total score, physical and psychosocial 
disability composite scores, and the work disability subscale score. 
Treatment Program 
 McCracken (2005) and Hayes et al. (1999) provide detailed information on the 
theoretical and practical aspects of the treatment model and methods. The treatment attended 
by patients was a form of ACT specifically designed for use with chronic pain patients being 
treated by an interdisciplinary team consisting of clinical psychology, physical therapy, 
occupational therapy, nursing, and medicine. Patients were treated on a three or four week 
course of treatment. While in treatment, patients lived independently in apartments adjacent to 
the hospital. Treatment sessions were provided five days per week for 6.5 hours daily. Each day 
included approximately 2.25 hours of physical conditioning, one hour of psychological methods, 
30 minutes of mindfulness training, and the remaining time was devoted to skills training or 
health/medical education. Treatment was primarily provided in a group format, although 
Acceptance and Values Three Year Follow-up     8 
 
 
individual sessions were also delivered approximately once per week. The fidelity of the 
treatment was maintained by appropriately designed treatment guides, supervision, three hours 
of clinical team meetings per week, and a once weekly hour long clinical seminar. 
Analyses 
In addition to the primary assessment points of pre-treatment and three-year follow-up, a 
number of analyses included outcomes at a three month follow-up appointment. Three month 
follow-up data were available for 81 (75%) of the individuals who had provided three year follow-
up data. While our earlier report on this cohort (Vowles & McCracken, 2008) detailed these 
three month outcomes, we felt that their inclusion within the present report allowed for 
comparisons at the different follow-up intervals and an examination of whether treatment gains 
had been maintained.  
Initially, a series of Analyses of Variance (ANOVAs) were performed to examine 
potential differences between participants who provided three year follow-up data and those 
who did not. These analyses were performed using both pre-treatment and three month follow-
up data.  
 Second, treatment outcomes across the pre-treatment, three month follow-up, and three 
year follow-up were assessed. Repeated measures ANOVAs were used for all variables with 
the exception of the work status variable for which a Wilcoxon signed ranks test was performed. 
Pairwise comparisons for the ANOVA’s used a Bonferroni-corrected alpha of .004.  
Given the number of nonresponders at the three year follow-up, a second set of 
ANOVA’s was also performed on the pre-treatment to three year follow-up data using an Intent-
to-Treat analysis. In this analysis, baseline scores were carried forward and used to replace 
missing three year follow-up data. While there are limitations to this approach to missing data 
(e.g., Beunckens, Molenberghs, & Kenward, 2005; Streiner, 2008), we felt it appropriately 
conservative to assume that all individuals who had not provided three year data were 
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continuing to function at baseline levels and that treatment was essentially ineffective at 
changing measures of outcome.  
 Third, within-subjects effect sizes (Cohen’s d), corrected for correlated data, were 
calculated using the formula of Dunlap et al. (1996).1 Confidence intervals (95%) for each effect 
size were also calculated using Becker’s (1998) formula to determine the standard error for 
repeated measures analyses. Supplementary Table S1 displays all formulae used (see also 
Nakagawa & Cuthill, 2007). Cohen (1988) suggested that effect sizes be interpreted as small 
when above 0.2, medium when above 0.5, and large when above 0.8. Absolute values are 
reported for all effect sizes such that greater values are associated with better treatment 
outcomes. 
 Fourth, we calculated reliable change between pre-treatment and both follow-up periods 
using the reliable change formulae of Jacobson and colleagues (1999). Reliable change is one 
aspect of clinical significance that identifies the amount of change required on a specific 
measure to exceed change that could be accounted for by measurement error. It uses temporal 
stability data for the measures (i.e., test-retest reliability) and SD’s at each time point to 
determine a standard error of the difference between assessment points. Using this value, a 
change score can be determined. If the change score of a particular patient exceeds the cut-
score, then that patient's score can be classified as reliably changed. Jacobson et al. (1999) 
describe the formulae used in detail. Consistent with previous analyses of this cohort of 
patients, reliable change analyses for three outcomes were performed including depression 
(BCMDI), disability (SIP), and pain-related anxiety and avoidance (PASS). These domains have 
been recommended as core outcomes by recent consensus panels (e.g. Dworkin et al., 2005). 
 Fifth, we examined how changes in two process measures, values-based action and 
acceptance of pain, related to changes in outcomes from pre-treatment through the three year 
follow-up. Residualized change scores for all measures were initially computed and correlations 
among process and outcome measures examined. Next, multiple regression analyses were 
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conducted to determine the amount of variance in residualized change in outcomes accounted 
for by residualized change in acceptance and values-based action, when considered together. 
Relevant background variables, including age, gender, education, and pain duration, were also 
tested for entry in the regressions.  
 A final set of analyses examined whether particular patient characteristics or patterns of 
treatment response could reliably predict treatment response at the three year follow-up. Using 
the three year follow-up reliable change data, participants were coded as either improved in at 
least one measure or not. Then two stepwise discriminant analyses were performed to 
determine if there were differences in pre-treatment or treatment response data among these 
two groups. The first included pre-treatment variables, including demographic information and 
questionnaire scores at treatment onset. The second included residualized changes in 
functioning from pre-treatment through three month follow-up.2 
Results 
Preliminary Analyses 
 There were only two differences between those who provided three year follow-up data 
and those who did not. Specifically, compared to those who did not provide data at the three-
month follow-up appointment, those who did provide data reported lower levels of physical 
disability, M = 0.09 (SD = 0.09) and M = 0.15 (SD = 0.13), F (1, 107) = 11.24, p < .001, and 
psychosocial disability M = 0.15 (SD = 0.14) and M = 0.22 (SD = 0.19), F (1, 107) = 5.35, p < 
.02.  There were no other differences indicated at either of the assessment points, including 
age, gender, marital status, work status, pain duration, pain intensity, pain-related surgeries, 
pain-related medical visits over the preceding six months, or any of the self-report measures.  
Significance Testing 
 All descriptive information is displayed in Table 1. For the pre-treatment to three month 
follow-up interval, significant improvement was indicated across all measures, all F’s > 21.89, all 
p’s < .001. For the pre-treatment to three year follow-up interval, significant improvements were 
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indicated across all measures with the exception of usual pain intensity, for which change was 
non-significant, F (1, 107) = 5.52, p = .021. All other F’s > 8.29, all other p’s < .004. Finally, for 
the interval between the three month and three year follow-up assessments, there was evidence 
of a significant decrease in two measures only, values-based action, F (1, 71) = 13.65, p < .001, 
and physical disability, F (1, 80) = 24.53, p < .001.  
 As noted, for the 58 individuals who did not respond, we replaced missing three-year 
data with pre-treatment scores for each individual, essentially assuming that these individuals 
had failed to derive benefit from treatment. We then performed a second set of repeated 
measures ANOVA’s integrating these replaced data. Again, a Bonferroni-controlled alpha of p = 
.004 was used. The results were almost identical to the ANOVA’s using complete cases only. 
Specifically, with one exception, significant improvements matched the results from the 
complete cases ANOVA’s, all F’s > 21.33, all p’s < .001. The sole exception was for the CPVI 
Values Success subscale, where the alpha fell just short of our required Bonferroni-controlled 
alpha, F (1, 165) = 8.30, p = .005. Change in usual pain intensity remained non-significant, F (1, 
165) = 5.63, p = .019. The results of these analyses are displayed in Supplementary Table S2. 
 For work status, the Wilcoxin Signed Ranks Test of change from pre-treatment to three 
year follow-up was non-significant, z = .1.34, p = .18. In the three years from treatment onset to 
follow-up, 17 individuals had returned to work, 11 had discontinued work, and the work status of 
the remaining individuals was unchanged. Descriptively, 29.6% of patients were working at 
pretreatment and 36.4% were working at three year follow-up. For those who were working at 
three-year follow-up, a repeated measures ANOVA was performed using the work disability 
subscale of the SIP. The results of this analysis indicated that disability for work significantly 
decreased from 0.36 (SD = 0.26) to 0.12 (SD = 0.15), F (1, 38) = 21.63, p < .001.  
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Effect Size Calculations 
  Effect sizes and 95% confidence intervals for all measures are displayed in Figure 1. 
The average effect size for the pre-treatment to three-month follow-up period was 0.76 (range: 
0.42 for pain intensity to 1.28 for acceptance of pain). Using the guidelines of Cohen (1988) with 
regard to effect size interpretation, effect sizes were large for acceptance of pain, depression, 
and pain-related anxiety, small for pain intensity, and medium for all other variables.  
 The average effect size in the pre-treatment to three-year follow-up period was 0.57 
(range: 0.28 for pain intensity to 0.85 for acceptance). Effect size was large for acceptance, 
medium for values discrepancy, depression, pain-related anxiety, psychosocial disability, and 
medical visits, and small for values success, pain intensity, and physical disability.  
Reliable Change Analyses 
 The results of the reliable change analyses at the 90% confidence interval for 
depression, pain-related anxiety, and disability are displayed in Table 2. In our previous report 
(Vowles & McCracken, 2008), we performed reliable change analyses using the total score of 
the SIP as we were unable to find individual test-retest data for the physical and psychosocial 
disability subscales. Given the divergence of SIP subscale scores observed in our analyses, 
with physical disability scores significantly worsening relative to three month follow-up while 
psychosocial disability scores did not, we felt it appropriate to perform separate reliable change 
analyses for the subscales using the test-retest estimate for the total score.  
Rates of reliable improvement were similar across all measures, averaging 46.2% 
(range: 45.0% – 46.9%) at the three month follow-up and 35.8% (range: 29.1% - 38.0%) at 
three year follow-up. When cases were evaluated on an individual basis, at the three month 
follow-up, 81.4% (n = 66) had reliably improved since treatment onset on one or more measure, 
53.1% (n = 43) on two or more, 33.3% (n = 27) on three or more, and 11.1% (n = 9) on all four. 
At the three year follow-up, 64.8% (n = 70) had improved on one or more measure, 36.1% (n = 
39) on two or more, 19.4% (n = 21) on three or more, and 9.3% (n = 10) on all four. 
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At three months, reliable decline occurred only for the Psychosocial Disability subscale 
of the SIP and only for 1.2% of individuals. At three years, rates of reliable decline averaged 
5.9% across the four measures (range: 4.7% to 6.9%). Individually, 13.0% (n = 14) had reliably 
declined since treatment onset on one or more measure, 4.6% (n = 5) on two or more, 2.8% (n 
= 3) on three or more, and 0.9% (n = 1) on all four. 
Treatment Process Analyses 
 Correlations among residualized change scores for acceptance and values-based action 
with residualized change scores in outcome measures are displayed in Table 3. These changes 
in the two treatment process measures were significantly correlated with changes in all except 
one measure of outcome, r range = 0.32, p < .005, to -0.75, p < .001. The sole exception was 
change in values-based action and change in pain-related medical visits, r = -.13, p = .20. 
Changes in acceptance and values-based action was also significantly correlated, r = 0.71, p < 
.001. 
 Multiple regressions were then performed for all outcome variables except pain intensity 
as there was no evidence of significant improvement at the three-year follow-up on that 
measure. Estimates of variance (Δ r2) and standardized regression coefficients (β) are displayed 
in Table 4. 
 Initially, demographic factors, including age, gender, education, and pain duration were 
statistically tested for entry. These variables did not enter as significant predictors in any of the 
equations. 
 When residualized changes in acceptance and values-based action were entered 
simultaneously, they accounted for significant variance in each of the five equations (range Δ r2 
= .11 to .61, average = .37). Significant regression coefficients were achieved across all 
equations as well. The coefficient for change in acceptance was significant in four of five 
equations, including change in depression, pain-related anxiety, physical disability, and medical 
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visits. The coefficient for change in values-based action was significant in three of five 
equations, including depression, pain-related anxiety, and psychosocial disability. 
Identification of Potential Predictors of Treatment Response 
 Two discriminant analyses were performed to determine if characteristics of treatment 
responders could be identified. As noted, treatment “response” was defined as having reliably 
improved in depression, pain-related anxiety, physical disability, or psychosocial disability at the 
three year follow-up. All variables were tested for entry in a statistical fashion. 
 The first analysis examined pre-treatment characteristics of patients, including 
demographic factors (i.e., gender, age, education, pain duration), and measures of treatment 
process (i.e., acceptance and values-based action) and outcome (i.e., pain intensity, 
depression, pain-related anxiety, physical and psychosocial disability, and medical visits). A 
significant discriminant function was not identified as none of the included variables was able to 
reliably discriminate between those who had reliably changed and those who had not. 
 The second analysis examined residualized change through three month follow-up and 
included residualized change in process and outcome measures as predictor variables. Only 
residualized change in psychosocial disability emerged as a significant predictor of treatment 
response, Wilks' λ = 0.88, F (1, 55) = 7.51, p = .008. The ability of residualized change in this 
variable to reliably classify individuals was modest however, 65.4%, which is only marginally 
greater than chance. In particular, the function was poor at accurately classifying those who had 
not reliably changed, 35.3%, although it was better in the classification of those who had, 
70.5%. 
Discussion 
The primary purpose of the present analyses was to determine longer term outcomes in 
a sample of individuals with chronic pain following a programme of interdisciplinary ACT. In 
brief, the results indicate that the functioning of patients was substantially improved three years 
following treatment completion relative to the start of treatment and that there was good 
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maintenance of gains relative to a follow-up conducted three months after treatment completion. 
To our knowledge, this study is the first to report long term outcomes of ACT for chronic pain.  
These data provide additional supportive evidence for the treatment approach as applied to 
chronic pain and for the overall theoretical and clinical model. 
 In addition to evidence regarding the statistically significant improvements achieved 
following treatment, we believe that there is a reasonable argument to be made for the clinical 
significance of the results, particularly given the complexity of the problems with pain 
experienced by this patient group. Effect sizes for outcome measures were medium at the three 
year follow-up for the majority of measures, including depression, pain-related anxiety, 
psychosocial disability, and pain-related healthcare visits, while they were small for physical 
disability. Further, the intent to treat analysis indicated significant change across all measures of 
outcome and all but one measure of treatment process. In brief, these analyses indicate that 
even when a “worst case” analysis was performed, assuming no improvement for those with 
missing data, there was still evidence of significant change across most measures. 
The effect size for reduction in pain was of a small size. Given that pain reduction is not 
an intended goal of the ACT-based treatment studied here, the lack of long-term pain reduction 
is not particularly surprising. One could interpret the improvements in pain intensity that have 
resulted from ACT for pain (e.g., Vowles & McCracken, 2008) as reflecting a reduction in pain-
related distress and interference with functioning, rather than a reduction in pain sensations per 
se. Regardless of the accuracy of this perspective, the present data support the contention that 
effective functioning is possible in a context of continuing pain. 
The results of the reliable change analyses indicate that almost two-thirds of treatment 
completers experienced a reliable improvement in depression, pain-related anxiety, 
psychosocial disability, or physical disability three years following treatment, while just over one-
third experienced a reliable improvement in two of these measures. A simple algebraic 
calculation of the proportion reliably improved relative to number needed to treat to see reliable 
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improvement in one individual would suggest that 1.5 individuals would need to be treated to 
see reliable improvement in one individual on at least one measure (i.e., 0.648/1.00 = 1/x) and 
2.8 individuals would need to be treated to see reliable improvement in one individual on at least 
two measures (i.e., 0.361/1.00 = 1/x). Using the same calculation with regard to reliable decline, 
7.7 individuals would need to be treated to see reliable decline in at least one measure (i.e., 
0.130/1.00 = 1/x) and 21.7 to see reliable decline in at least two measures (i.e., 0.046/1.00 = 
1/x). Given the initial complexity of the pain experience and significant amount of time that had 
passed since treatment completion, the fact that so many individuals had reliably improved, 
while only a minority had reliably worsened, provides added support for the durability of 
improvement following the treatment that was provided.  
Furthermore, as previously described (Vowles & McCracken, 2008), the calculation of 
reliable change is one of two components of the clinically significant change approach proposed 
by Jacobson and colleagues (1999). The second component involves a determination of 
whether scores for each individual case move from a “clinical” to a “recovered” distribution and 
ideally this requires normative data from the latter distribution, which to our knowledge is not 
available for chronic pain. While there are other methods that have been used to determine this 
second aspect of clinically significant change (e.g., a shift of 2 or more standard deviations; 
Jacobson et al., 1999), we would argue that these are not particularly appropriate for chronic 
conditions where “recovery” is not synonymous with an absence of symptoms as can be the 
observed in conditions where symptom remission is possible (e.g., major depressive disorder; 
see Jacobson et al. for an example). Therefore, it seems necessary for the field to collect data 
from a larger sample of “recovered” individuals with chronic pain in order to provide a more 
robust and appropriate normative sample. Until such time as a large sample can be collected, 
we suggest that the present data can serve as at least a preliminary sample of such individuals, 
meaning that, on the whole, the three year responders appear to be functioning effectively 
within a context of continuing pain and could reasonably be considered as recovered. 
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There were two variables for which there was seemingly a loss of treatment effect, as a 
significant worsening of scores was observed between the three month and three year follow-up 
assessments even though both remained improved relative to treatment onset. An extended 
discussion for both variables seems warranted. 
For physical disability, just under half of the improvements were lost at the three-year 
follow-up in comparison to improvements seen at the three month follow-up. While this 
decrease in treatment effect is obviously substantial, when one evaluates it in relation to the 
maintenance of treatment gains across all other measures of outcome, the magnitude of the 
decline in physical disability seems inconsistent. If gains in physical disability were lost within a 
context of worsening scores in all other measures of outcome, then perhaps there would be a 
stronger case against long-term benefit of the treatment overall. This specific loss of some 
improvements in physical disability clearly is not uniform in the sample but rather happens to a 
greater degree is some people compared to others.  It could be useful to further explore the 
roots of this reduction in physical functioning in some of these individuals.   
The second variable for which there was evidence for a loss of treatment effect was for 
values-based action.  Given the prominence of the focus on values clarity and values-based 
action within the ACT treatment model, this could point to a weakness in the methods being 
used. It is curious, however, that values success decreases between the two follow-up periods, 
while the discrepancy between values importance and values success does not. The 
interpretation of these two seemingly divergent results is obviously complex, although it can be 
explained at a statistical level by the reduction in values importance scores between pre-
treatment and the three year follow-up. One possibility is that values-related methods are more 
vulnerable to a loss of effect and are more likely to need some type of reinforcement during 
follow-up intervals.  
Results of treatment process analyses are similar to those from previous studies 
(McCracken, Vowles, & Eccleston, 2005; Vowles, McCracken, & Eccleston, 2007; Vowles & 
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McCracken, 2008) in that changes in pain acceptance and values-based action through the 
three year follow-up accounted for significant variance in changes in overall functioning over the 
same interval. In some of these analyses, the percentage of variance that was accounted for is 
substantial. For example, improvements in these two measures accounted for 53% of the 
variance in improvements in depression, 61% of the variance in improvements for pain-related 
anxiety, and 37% of the variance in improvements in psychosocial disability, in addition to the 
lesser amounts of the variance accounted for in improvements in physical disability and 
reductions in pain-related healthcare visits, 22% and 11%, respectively. The larger magnitudes 
here are substantial and provide additional support for this process-oriented treatment provided, 
in that two of the key treatment processes targeted are strongly related to overall levels of 
improvement.  
It is worth nothing that the regression analyses do not allow any conclusions regarding 
causality. Instead, they only allow us to draw conclusions with regard to patterns of change 
across variables; in this case, change in our process variables accounted for significant change 
in our outcome measures. True tests of causality in research such as this are difficult to carry 
out. As an alternative, researchers often look for a pattern of findings across different studies 
and different approaches to help bolster the strength with which causal conclusions can be 
drawn. At the present time, there is relatively broad support for the relevance of the processes 
studied here on patient outcomes. In particular, there are data available which parallel these 
findings in measures of chronic pain “coping” behaviors (McCracken & Vowles, 2007; Vowles & 
McCracken, 2010) and experimental settings with chronic pain patients (Vowles et al., 2007). 
Further, there is now evidence that these processes have a mediating effect on chronic pain 
treatment outcomes (Wicksell, Olsson, & Hayes, 2010). Regardless, continued work in this area 
is a priority to allow a more clear understanding of active treatment processes, as well as how 
these processes serve to influence treatment outcomes. 
Acceptance and Values Three Year Follow-up     19 
 
 
 In the discriminant analyses examining whether pre-treatment or change through three-
month follow-up data could be used to reliably predict treatment response, only a single variable 
emerged as a significant predictor and its value was marginal overall and fairly poor at 
predicting an absence of reliable change. One the one hand, these results simply add to a 
larger pool of analyses that have generally failed to find reliable predictors of treatment 
response (e.g., see the review of McCracken & Turk, 2002). It is interesting that changes in our 
processes measures were related to changes in outcome within the regression analyses, but 
changes in these same variables were not able to predict the frequency of reliable change. This 
lack of prediction could be due to a number of factors, including the long interval between 
follow-up and the last clinical contact (2.75 years), differences in the statistical methodologies 
used in the regression and discriminant analyses, or perhaps the difficulty inherent in measuring 
complex human behavior using a self-report questionnaire. It is also possible that further 
refinement is needed in our definition and measurement of hypothesized “active” treatment 
processes in order to derive more accurate predictive models of longer term functioning with 
chronic pain. On the other hand, it may be that these results suggest that ACT for chronic pain 
may be of use to patients presenting with a variety of demographic, psychosocial, and physical 
characteristics. Obviously, this conclusion cannot be drawn with certainty and further data are 
needed. 
 There are limitations to acknowledge. First, the overall response rate was a relatively 
modest 65.1%, although it fell only slightly short of the 70% cut point recommended by Peat et 
al. (2001) following a UK national survey of interdisciplinary pain programmes and the follow-up 
period used here was considerably longer than the survey period of less than one year used by 
Peat and colleagues to identify that cut-point. The severity of this limitation is perhaps 
diminished by the last observation carried forward algorithm that we used for missing data; 
nonetheless, it may be that the overall pattern of results would have been different if response 
rates had been higher. 
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 Second, there was no control group used. While this does mean that we are not able to 
draw any firm conclusions with regard to longer term functioning in the absence of treatment, 
the magnitude of this limitation is attenuated to some extent by a number of considerations. For 
example, these patients had complex, disabling, and longstanding pain at treatment onset and 
were, on the whole, functioning much better three years following treatment conclusion across 
multiple domains of functioning, a pattern of results that would seem highly unlikely in the 
absence of some type of treatment effect. Furthermore, the treatment provided took place within 
an existing clinical service, as opposed to being part of a tightly controlled clinical trial, and 
therefore included a broad mix of relatively unselected patients suffering significantly as a result 
of pain.   
 Finally, assessment measures were entirely self-report and it may be that method 
variance accounted for some proportion of the pattern of findings. The collection of measures of 
observed physical, vocational, or social functioning would have provided a potentially fuller 
understanding of longer-term functioning.   
 The effectiveness of ACT for chronic pain is increasingly well-established. It has recently 
been added as an intervention with modest support to the empirically supported treatment list 
maintained by the American Psychological Association’s Division of Clinical Psychology (see 
http://www.div12.org/PsychologicalTreatments/disorders/pain_general.php). Interest and 
empirical work in this area has advanced fairly rapidly since the first published study in this area 
(McCracken, 1998) and the first published trial (Dahl, Wilson, & Nilsson, 2004). It now seems 
reasonable to conclude that individuals with chronic pain can approach their pain, and the 
suffering naturally occasioned by it, in a manner that more flexibly entails willingness to have 
pain, openness to experience, clarity in values, and with an allegiance between behavior and 
these values. Further, it seems that responding to pain in this way is related to improvements in 
functioning not only over the months immediately following treatment, but over the longer term 
as well.  
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Footnotes 
1 While the calculation of effect size used here differs from our previous report (Vowles & 
McCracken, 2008), controlling for correlated data appears the more conservative estimate and 
was therefore used. 
2 We also performed a discriminant analyses using residualized change in process and outcome 
data from pre to post-treatment in this cohort. As post-treatment data are not detailed within this 
report and a significant discriminant function was not identified using these data, these results 
are not reported here. 
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Figure Caption 
Within-subjects effect size statistics (Cohen’s d), controlled for within participant correlations, 
with 95% Confidence Intervals. Vertical reference lines in the figure represent small (0.2), 
medium (0.5), and large (0.8) effect sizes. 
 
